Concepedia

Wally Meyer

WM

Statistics

Publications

10

Citations

314

H-Index

10

Active since

1987

Affiliations

Reliance Industries (United States)(Current)

Baylor University Medical Center

Wally Meyer is an author at Reliance Industries (United States) specializing in oncology, chemotherapy, and medicine.

Publications per year

1987–2013

10

Publications

10

Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide

R. Nave, Wally Meyer, Rainer Fuhst et al. · Pulmonary Pharmacology & Therapeutics · 2005 · 81 citations

Pharmacy, Pharmacology, Toxicology +14

Double‐blind, placebo‐controlled, dose‐ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber

Wally Meyer, Annemie Narkus, A. Salapatek et al. · Allergy · 2013 · 71 citations

Life Sciences, Immunology, Pharmacotherapy +17

Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.

John Nemunaitis, C Bohart, T. Fong et al. · PubMed · 1999 · 38 citations

Medicine, Immunology, Oncology +15

Irinotecan Hydrochloride (CPT-11) Resistance Identified by K-ras Mutation in Patients with Progressive Colon Cancer After Treatment with 5-Fluorouracil (5-FU)

John Nemunaitis, John V. Cox, Wally Meyer et al. · American Journal of Clinical Oncology · 1997 · 34 citations

Medicine, Molecular Genetics, Oncology +16

Early results from Children's Oncology Group (COG) ARST0431: Intensive multidrug therapy for patients with metastatic rhabdomyosarcoma (RMS).

Brenda J. Weigel, Elizabeth Lyden, John R. Anderson et al. · Journal of Clinical Oncology · 2010 · 22 citations

Medicine, Oncology, Radiation Oncology +15

1–5 of 10